Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DEFLAZACORT vs DELAMANID: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DEFLAZACORT vs DELAMANID: Safety Overview

Metric DEFLAZACORT DELAMANID
Total FAERS Reports 3,831 1,646
Deaths Reported 149 496
Death Rate 3.9% 30.1%
Hospitalizations 592 695
Average Patient Age 25.7 yrs 38.4 yrs
% Female Patients 15.1% 43.4%
FDA Approval Date Apr 25, 2024 N/A
Manufacturer Cranbury Pharmaceuticals, LLC N/A
Route ORAL N/A
Marketing Status Prescription N/A